Carsten Grüllich Selected Research

Formaldehyde (Formol)

1/2020

High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carsten Grüllich Research Topics

Disease

26	Neoplasms (Cancer) 12/2023 - 05/2005
17	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 08/2014
15	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2014
7	Neoplasm Metastasis (Metastasis) 07/2018 - 01/2014
4	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2012 - 05/2004
3	Leukemia 12/2009 - 09/2008
2	Kidney Neoplasms (Kidney Cancer) 12/2023 - 06/2015
2	Fatigue 01/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 04/2019 - 01/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2018 - 01/2017
2	Lymphatic Metastasis 01/2018 - 01/2014
2	medullary Thyroid cancer 01/2018 - 01/2014
1	Bites and Stings (Sting) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Microsatellite Instability 01/2020
1	COVID-19 01/2020
1	Urologic Neoplasms (Urological Cancer) 12/2019
1	Adenocarcinoma 04/2019
1	Adenoma (Adenomas) 04/2019
1	Carcinoid Tumor (Carcinoid) 01/2019
1	Genomic Instability 01/2018
1	Chromosomal Instability (Chromosome Stability) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Residual Neoplasm 06/2017
1	Hashimoto's encephalitis 07/2015
1	Brain Diseases (Brain Disorder) 07/2015
1	Hashimoto Disease (Thyroiditis, Hashimoto) 07/2015
1	Retinoblastoma (Glioblastoma, Retinal) 10/2014
1	Sarcoma (Soft Tissue Sarcoma) 05/2014
1	Radiodermatitis 05/2014

Drug/Important Bio-Agent (IBA)

4	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2012
4	Everolimus FDA Link 01/2020 - 07/2017
3	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2019
3	cabozantinibIBA 01/2020 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2015
3	Docetaxel (Taxotere)FDA Link 01/2017 - 06/2015
2	NivolumabIBA 12/2023 - 09/2017
2	AntigensIBA 01/2023 - 11/2018
2	PasotuxizumabIBA 01/2023 - 01/2021
2	PlatinumIBA 04/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 06/2017
2	Abiraterone AcetateIBA 01/2017 - 06/2015
2	Granzymes (Granzyme)IBA 12/2013 - 09/2008
2	Thomsen-Friedenreich antibodiesIBA 06/2012 - 02/2009
2	GlobulinsIBA 06/2012 - 02/2009
1	ParaffinIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	atezolizumabIBA 01/2020
1	ribalIBA 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	LipidsIBA 12/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2019
1	Cytochrome P-450 CYP3AIBA 04/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2019
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2019
1	Radioisotopes (Radionuclides)IBA 01/2019
1	Peptide Receptors (Peptide Receptor)IBA 01/2019
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	lenvatinibIBA 01/2018
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	MTOR InhibitorsIBA 07/2017
1	pazopanib FDA Link 07/2017
1	enzalutamideIBA 01/2017
1	cabazitaxel FDA Link 01/2017
1	Radium-223IBA 01/2017
1	AntibodiesIBA 01/2017
1	taxaneIBA 01/2017
1	Iodide Peroxidase (Deiodinase)IBA 07/2015
1	anti-thyroglobulinIBA 07/2015
1	IpilimumabIBA 07/2015
1	Anti-Idiotypic AntibodiesIBA 07/2015
1	Methylprednisolone FDA LinkGeneric 07/2015
1	abirateroneIBA 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 02/2015
1	Hormones (Hormone)IBA 02/2015
1	ProteomeIBA 02/2015
1	nilotinib FDA Link 02/2015
1	PhosphotyrosineIBA 02/2015
1	Androgen Receptors (Androgen Receptor)IBA 10/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2014
1	AndrogensIBA 01/2014

Therapy/Procedure

23	Therapeutics 12/2023 - 05/2005
8	Drug Therapy (Chemotherapy) 12/2020 - 02/2015
7	Castration 01/2023 - 10/2014
6	Immunotherapy 12/2023 - 07/2015
3	Cell Transplantation 06/2012 - 05/2005
2	Adjuvant Chemotherapy 01/2020 - 05/2014
2	Stem Cell Transplantation 01/2017 - 02/2009
2	Radiotherapy 12/2014 - 05/2014
1	Prostatectomy (Retropubic Prostatectomy) 01/2018
1	Salvage Therapy 05/2016